Research identifies marker for aggressive ovarian cancer
April 26, 2017Research and Development Cancer, ovarian cancer
Scientists have identified a marker which they believe can inform whether a tumour will become more aggressive and pose a …
Sanofi launches lawsuit against Mylan over “illegal business practices”
April 26, 2017Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit
In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …
The May 2017 issue of Pharmafocus is now live!
April 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus
The latest edition of Pharmafocus is available to read now! In this issue we delve into pharma’s reaction to the …
Rasna Therapeutics appoints new CEO
April 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Rasna Therapeutics, the UK-based biotech that specialises in developing treatments for leukaemia, has announced the appointment of a new CEO. …
Pharma industry calls for EMA relocation by June in open EFPIA letter
April 25, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA
Heads of research from 19 of the biggest players in the industry have called for a decision to be made …
Indian government goes to war over 75% stent price reduction
April 25, 2017Manufacturing and Production India, cardiac stents
The National Pharmaceutical Pricing Authority (NPPA), India’s drug pricing regulator, moved to lower the price of the newest generation of …
EMA gives positive opinion on Biogen’s spinal muscular atrophy drug Spinraza
April 25, 2017Manufacturing and Production, Sales and Marketing Biogen, Ionis, Spinraza, spinal muscular atrophy
Biogen has revealed that Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA) , has received a positive opinion from …
Quarter of cancer patients visit GP three times with no diagnosis
April 25, 2017Manufacturing and Production, Research and Development Cancer, GP, NHS, oncology
A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …
Japanese pharma expects 17% growth throughout 2017
April 25, 2017Manufacturing and Production CPhI, Japan
Pharma companies attending CPhI Japan are expecting a 17% growth of the country’s market throughout the year, according to data …
Five crucial facts about mental health
April 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day
7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …
Psoriasis drug Siliq will be cheapest in class, Valeant reveals
April 24, 2017Sales and Marketing Siliq, Valeant, psoriasis
Canadian pharmaceutical firm Valeant has announced the list price for its psoriasis treat Siliq (brodalumab) will stand at $3,500 a …
Breakthrough multiple sclerosis research sheds light on cause of the disease
April 24, 2017Research and Development, Sales and Marketing multiple sclerosis
Researchers from the Universities of Exeter and Alberta have identified a protein in the brain which they believe could be …
Janssen acquires over 90% of Actelion
April 24, 2017Sales and Marketing Actelion, Janssen
Actelion has revealed that, following the wrap of its $30 billion deal in January, Janssen Holding has acquired 92.51% of …
EU recommendation for Sanofi and Regeneron’s arthritis treatment
April 24, 2017Sales and Marketing Kevzara, NICE, sarilumab
Sanofi and Regeneron are celebrating the news that their treatment Kevzara (sarilumab) has received a positive opinion from the EMA’s …
England “really is not a good place” to get cancer, BMS UK General Manager says
April 24, 2017Medical Communications, Research and Development, Sales and Marketing BMS, NICE, opdivo
Bristol-Myers Squibb’s UK General Manager Ben Hickey has slammed NICE over its assessment criteria and process in recommending access to …
Applied DNA Sciences agrees deal for bulk DNA manufacturing
April 21, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Applied DNA sciences, DNA manufacture
In a deal that sounds more like something to come out of a science-fiction novel, Applied DNA Sciences has agreed …
FDA restricts administration of strong pain killers to children
April 21, 2017Medical Communications, Sales and Marketing FDA, opioid
The FDA has announced that it will require medication including codeine and tramadol, two high-strength painkillers, to have its strongest …
Top Ten most popular articles on Pharmafile.com this week
April 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Another week has whizzed round again as we race into Spring, and a breadth of stories have piqued the interests …
Teva launches competitors to GSK’s Advair inhaler
April 21, 2017Medical Communications, Sales and Marketing Advair, AirDuo, GSK, Teva, asthma
GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the …
Pharma deal-making: In the pink of health
April 21, 2017Medical Communications pharmafile
Deal-making in the global pharmaceuticals sector is booming, with no signs of slowing down, as this report from Aranca indicates.2015 …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
